ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,421.03
      0.85%
      US Tech 100
      19,067.60
      1.85%
      Dow Jones
      38,712.21
      -0.09%
      Brent Oil
      82.025
      -0.33%
      Bitcoin
      68,089.52
      -0.23%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Karolinska Development Ab (0P3C)

      7. Karolinska Development Ab (0P3C) News

      0P3C

      Karolinska Development Ab (0P3C)

      Karolinska Development Ab
      		Date:
      Sort by:
       Showing the most relevant articles for your search:LSE:0P3C
      DateTimeSourceHeadlineSymbolCompany
      06/12/20246:34AMUK RegulatoryKarolinska Development’s portfolio company Biosergen gets final approval to test lead candidate BSG005 in patients with invasive fungal infectionLSE:0P3CKarolinska Development Ab
      05/28/20242:00AMUK RegulatoryKarolinska Development invests in BOOST Pharma, expanding its portfolioLSE:0P3CKarolinska Development Ab
      05/16/202410:40AMUK RegulatoryKarolinska Development’s Annual General Meeting 2024LSE:0P3CKarolinska Development Ab
      05/08/20243:30AMUK RegulatoryKarolinska Development’s portfolio company Umecrine Cognition initiates second part of clinical phase 1a/2 study in PBCLSE:0P3CKarolinska Development Ab
      04/26/20242:00AMUK RegulatoryInterim Report - January-March 2024LSE:0P3CKarolinska Development Ab
      04/16/20242:00AMUK RegulatoryNotice of Annual General Meeting in Karolinska Development AB (publ)LSE:0P3CKarolinska Development Ab
      03/22/20244:30AMUK RegulatoryKarolinska Development’s portfolio company Umecrine Cognition presents positive safety data from the first part of its Phase 1b/2 study in PBCLSE:0P3CKarolinska Development Ab
      03/22/20243:00AMUK RegulatoryKarolinska Development Annual Report 2023 publishedLSE:0P3CKarolinska Development Ab
      03/14/20247:48AMUK RegulatoryKarolinska Development’s portfolio company Aprea Therapeutics receives FDA IND approval and secures funding of USD 34 millionLSE:0P3CKarolinska Development Ab
      03/14/20246:24AMUK RegulatoryKarolinska Development’s portfolio company Biosergen publishes prospectus due to rights issue of unitsLSE:0P3CKarolinska Development Ab
      03/06/20243:00AMUK RegulatoryKarolinska Development’s portfolio company Umecrine Cognition presents preclinical Parkinson’s data on golexanolone at AD/PDLSE:0P3CKarolinska Development Ab
      02/16/20242:00AMUK RegulatoryYear-end Report - January-December 2023LSE:0P3CKarolinska Development Ab
       Showing the most relevant articles for your search:LSE:0P3C

      Your Recent History

      NYSE
      PSE
      Delayed Upgrade Clock